Elon's Vision
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Investing

Emma Watson’s gin brand nets £5m as Renais plots global expansion

by
January 9, 2025
in Investing
0
Emma Watson’s gin brand nets £5m as Renais plots global expansion
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Emma Watson’s premium gin venture Renais has raised nearly £5 million to speed up its global expansion, building on its reputation for sustainable production and strong international demand.

Co-founded by the Harry Potter star and her brother, Alex Watson, the Dorset-distilled gin uses grapes sourced from the Burgundy region, including a small proportion from the family’s own vineyard in Chablis.

Despite a backdrop of economic and political uncertainty — with Donald Trump’s inauguration and proposed US tariffs on British imports — Alex Watson remains optimistic about Renais’s prospects in the American market. He plans to use the fresh capital injection to “crack a bit more deeply” into the US, where Renais launched last year.

Closer to home, the brand’s expansion into Europe continues apace, with plans to debut in physical stores across Spain and France by the end of the year. Currently available in 11 countries, Renais has distribution agreements in 22 markets and is looking to add Dubai and Canada to its roster over the coming months.

Funding has come courtesy of InvestBev, a US-based private equity firm specialising in drinks, and Jean-Sébastien Robicquet, the founder of French spirits group Maison Villevert. Renais has also strengthened its leadership with the appointment of Jimmy Weir, former group chief financial officer of Lathwaites, to its board.

Although both Watson siblings co-founded the business in 2023, Alex serves as chief executive while Emma, 34, holds the position of “creative director”. Best known for her role as Hermione Granger in the Harry Potter films, she oversees the brand’s creative vision, including special editions such as limited-edition bottle sleeves, while her brother brings industry expertise from his time at Diageo.

In a bid to position itself as a forward-thinking, eco-conscious spirits producer, Renais incorporates grape skins leftover from the wine-making process into its distillation, uses biodegradable packaging made from mushroom-based materials and operates solar-powered distilleries. These efforts, combined with its premium positioning, come at a cost: Renais retails at £48 a bottle.

Alex Watson remains confident that discerning customers will be willing to pay a premium for a sustainable tipple. “Consumers are happy to pay a little bit more to know that something is produced responsibly and sustainably,” he said.

Read more:
Emma Watson’s gin brand nets £5m as Renais plots global expansion

Previous Post

Food inflation poised to jump above 4% as levies and wage rises weigh on retailers

Next Post

The Dollar Dilemma: Where to from Here

Next Post

The Dollar Dilemma: Where to from Here

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

Microsoft Planner vs Trello: Which Project Management Tool is Better?

May 24, 2023

An update on the National Nature Assessment

April 23, 2025

That Bangladesh Mask Study!

December 1, 2021
Friday Feature: Scholé Center for Innovative Education

Friday Feature: Scholé Center for Innovative Education

0

0

0

0
Friday Feature: Scholé Center for Innovative Education

Friday Feature: Scholé Center for Innovative Education

November 14, 2025

Is Your Business on the Nice List This Christmas?

November 14, 2025
A Tale of Two Cannabinoids: Congress’s Protectionist Pivot and Policy Dissonance

A Tale of Two Cannabinoids: Congress’s Protectionist Pivot and Policy Dissonance

November 14, 2025
Experts say there is “nothing to fear” from Employment Rights Bill as employers back fairer workplace reforms

Experts say there is “nothing to fear” from Employment Rights Bill as employers back fairer workplace reforms

November 14, 2025

Recent News

Friday Feature: Scholé Center for Innovative Education

Friday Feature: Scholé Center for Innovative Education

November 14, 2025

Is Your Business on the Nice List This Christmas?

November 14, 2025
A Tale of Two Cannabinoids: Congress’s Protectionist Pivot and Policy Dissonance

A Tale of Two Cannabinoids: Congress’s Protectionist Pivot and Policy Dissonance

November 14, 2025
Experts say there is “nothing to fear” from Employment Rights Bill as employers back fairer workplace reforms

Experts say there is “nothing to fear” from Employment Rights Bill as employers back fairer workplace reforms

November 14, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.